Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

666 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, Gay RE, Michel BA, Brühlmann P, Müller-Ladner U, Gay S, Matucci-Cerinic M. Distler O, et al. Arthritis Res. 2002;4(6):R11. doi: 10.1186/ar596. Epub 2002 Aug 30. Arthritis Res. 2002. PMID: 12453314 Free PMC article.
Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathways.
Distler JH, Hagen C, Hirth A, Müller-Ladner U, Lorenz HM, del Rosso A, Michel BA, Gay RE, Nanagara R, Nishioka K, Matucci-Cerinic M, Kalden JR, Gay S, Distler O. Distler JH, et al. Among authors: distler o. Mol Pharmacol. 2004 Feb;65(2):389-99. doi: 10.1124/mol.65.2.389. Mol Pharmacol. 2004. PMID: 14742681
Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis.
Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, Michel BA, Gay RE, Müller-Ladner U, Matucci-Cerinic M, Plate KH, Gassmann M, Gay S. Distler O, et al. Among authors: distler jh. Circ Res. 2004 Jul 9;95(1):109-16. doi: 10.1161/01.RES.0000134644.89917.96. Epub 2004 Jun 3. Circ Res. 2004. PMID: 15178641
Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Distler JH, Jüngel A, Kowal-Bielecka O, Michel BA, Gay RE, Sprott H, Matucci-Cerinic M, Chilla M, Reich K, Kalden JR, Müller-Ladner U, Lorenz HM, Gay S, Distler O. Distler JH, et al. Among authors: distler o. Arthritis Rheum. 2005 Mar;52(3):856-64. doi: 10.1002/art.20883. Arthritis Rheum. 2005. PMID: 15751077 Free article.
Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells.
Distler JH, Jüngel A, Caretto D, Schulze-Horsel U, Kowal-Bielecka O, Gay RE, Michel BA, Müller-Ladner U, Kalden JR, Gay S, Distler O. Distler JH, et al. Among authors: distler o. Arthritis Rheum. 2006 Jan;54(1):214-25. doi: 10.1002/art.21497. Arthritis Rheum. 2006. PMID: 16385517 Free article.
Angiogenesis and vasculogenesis in systemic sclerosis.
Distler JH, Gay S, Distler O. Distler JH, et al. Among authors: distler o. Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii26-7. doi: 10.1093/rheumatology/kel295. Rheumatology (Oxford). 2006. PMID: 16987827 Review.
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells.
Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, Akhmetshina A, Walker UA, Gabrielli A, Müller-Ladner U, Tyndall A, Matucci-Cerinic M, Distler O; EULAR Scleroderma Trials and Research group. Distler JH, et al. Among authors: distler o. Ann Rheum Dis. 2009 Feb;68(2):163-8. doi: 10.1136/ard.2008.091918. Epub 2008 Jul 23. Ann Rheum Dis. 2009. PMID: 18653485 Free article.
666 results